These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23658444)

  • 1. Specific amino acid substitutions in the S protein prevent its excretion in vitro and may contribute to occult hepatitis B virus infection.
    Biswas S; Candotti D; Allain JP
    J Virol; 2013 Jul; 87(14):7882-92. PubMed ID: 23658444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of core protein mutations in the development of occult HBV infection.
    Chen J; Liu B; Tang X; Zheng X; Lu J; Zhang L; Wang W; Candotti D; Fu Y; Allain JP; Li C; Li L; Li T
    J Hepatol; 2021 Jun; 74(6):1303-1314. PubMed ID: 33453326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell responses and viral variability in blood donation candidates with occult hepatitis B infection.
    Bes M; Vargas V; Piron M; Casamitjana N; Esteban JI; Vilanova N; Pinacho A; Quer J; Puig L; Guardia J; Sauleda S
    J Hepatol; 2012 Apr; 56(4):765-74. PubMed ID: 22173156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of hepatitis B virus surface protein mutations on the diagnosis of occult hepatitis B virus infection.
    El Chaar M; Candotti D; Crowther RA; Allain JP
    Hepatology; 2010 Nov; 52(5):1600-10. PubMed ID: 20815025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occult hepatitis B virus infection: influence of S protein variants.
    Zhang Z; Zhang L; Dai Y; Zhang Y; Li J; Li X
    Virol J; 2016 Jan; 13():10. PubMed ID: 26786229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of occult hepatitis B virus infection in anti-hbc positive patients from a liver clinic.
    Martinez MC; Kok CC; Baleriola C; Robertson P; Rawlinson WD
    PLoS One; 2015; 10(3):e0117275. PubMed ID: 25763579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of occult hepatitis B virus infection from blood donors in China.
    Zheng X; Ye X; Zhang L; Wang W; Shuai L; Wang A; Zeng J; Candotti D; Allain JP; Li C
    J Clin Microbiol; 2011 May; 49(5):1730-7. PubMed ID: 21411575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of mutations in hepatitis B virus surface protein on viral antigenicity and phenotype in occult HBV strains from blood donors.
    Huang CH; Yuan Q; Chen PJ; Zhang YL; Chen CR; Zheng QB; Yeh SH; Yu H; Xue Y; Chen YX; Liu PG; Ge SX; Zhang J; Xia NS
    J Hepatol; 2012 Oct; 57(4):720-9. PubMed ID: 22634131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection.
    Svicher V; Cento V; Bernassola M; Neumann-Fraune M; Van Hemert F; Chen M; Salpini R; Liu C; Longo R; Visca M; Romano S; Micheli V; Bertoli A; Gori C; Ceccherini-Silberstein F; Sarrecchia C; Andreoni M; Angelico M; Ursitti A; Spanò A; Zhang JM; Verheyen J; Cappiello G; Perno CF
    Antiviral Res; 2012 Jan; 93(1):86-93. PubMed ID: 22086128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HBsAg mutations related to occult hepatitis B virus infection in HIV-positive patients result in a reduced secretion and conformational changes of HBsAg.
    Sadeghi A; Shirvani-Dastgerdi E; Tacke F; Yagmur E; Poortahmasebi V; Poorebrahim M; Mohraz M; Hajabdolbaghi M; Rasoolinejad M; Abbasian L; Jafari R; Fakhari Z; Norouzi M; Ebrahimian A; Geravand B; Alavian SM; Jazayeri SM
    J Med Virol; 2017 Feb; 89(2):246-256. PubMed ID: 27381922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic characterization and genotyping of hepatitis B virus (HBV) isolates from donors with an occult HBV infection.
    Chamni N; Louisirirotchanakul S; Oota S; Sakuldamrongpanish T; Saldanha J; Chongkolwatana V; Phikulsod S
    Vox Sang; 2014 Nov; 107(4):324-32. PubMed ID: 25040474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of mutations in the S gene of hepatitis B virus in HIV positive Mexican patients with occult hepatitis B virus infection.
    Enriquez-Navarro K; Maldonado-Rodriguez A; Rojas-Montes O; Torres-Ibarra R; Bucio-Ortiz L; De la Cruz MA; Torres-Flores J; Xoconostle-Cazares B; Lira R
    Ann Hepatol; 2020; 19(5):507-515. PubMed ID: 32592870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of S protein transmembrane domain mutations in the development of occult hepatitis B virus infection.
    Jiang X; Chang L; Yan Y; Ji H; Sun H; Xiao Y; Song S; Feng K; Nuermaimaiti A; Wang L
    Emerg Microbes Infect; 2022 Dec; 11(1):2184-2196. PubMed ID: 35976035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of hepatitis B virus (HBV) DNA screening and characterization of acute and occult HBV infections among blood donors from Madrid, Spain.
    González R; Torres P; Castro E; Barbolla L; Candotti D; Koppelman M; Zaaijer HL; Lelie N; Allain JP; Echevarría JM
    Transfusion; 2010 Jan; 50(1):221-30. PubMed ID: 19682332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A computational approach to identify point mutations associated with occult hepatitis B: significant mutations affect coding regions but not regulative elements of HBV.
    Bruni R; Prosperi M; Marcantonio C; Amadori A; Villano U; Tritarelli E; Lo Presti A; Ciccozzi M; Ciccaglione AR
    Virol J; 2011 Aug; 8():394. PubMed ID: 21824402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occult HBV infection in patients with autoimmune hepatitis: A virological and clinical study.
    Chen XX; Xiang KH; Zhang HP; Kong XS; Huang CY; Liu YM; Lou JL; Gao ZH; Yan HP
    J Microbiol Immunol Infect; 2020 Dec; 53(6):946-954. PubMed ID: 31153830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced antigenicity of naturally occurring hepatitis B surface antigen variants with substitutions at the amino acid residue 126.
    Qiu S; Zhang J; Tian Y; Yang Y; Huang H; Yang D; Lu M; Xu Y
    Intervirology; 2008; 51(6):400-6. PubMed ID: 19258718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High rate of occult hepatitis B virus infection in hemodialysis units of KwaZulu-Natal, South Africa.
    Msomi N; Ndlovu K; Giandhari J; Wilkinson E; Parboosing R; Zungu S; Mlisana K
    J Med Virol; 2019 Oct; 91(10):1797-1803. PubMed ID: 31180137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of occult hepatitis B virus from blood donors carrying genotype A2 or genotype D strains.
    Candotti D; Grabarczyk P; Ghiazza P; Roig R; Casamitjana N; Iudicone P; Schmidt M; Bird A; Crookes R; Brojer E; Miceli M; Amiri A; Li C; Allain JP
    J Hepatol; 2008 Oct; 49(4):537-47. PubMed ID: 18602718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occult Hepatitis B Virus Infection in Maintenance Hemodialysis Patients: Prevalence and Mutations in "a" Determinant.
    Tang Y; Liu X; Lu X; He Q; Li G; Zou Y
    Int J Med Sci; 2020; 17(15):2299-2305. PubMed ID: 32922195
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.